Learn how the free light chain (FLC) assay has revolutionized the care of diseases caused by the systemic proteotoxic effect exerted by light chains, such as AL amyloidosis, light chain deposition disease, and monoclonal gammopathies of renal significance.
Dept. of Neurology, University Hospital Ulm Marburg
Update Multiple Sclerosis
Presented by: Luigi M. Biasucci
University-Hospital of Padova, Italy
In the last decade, Cystatin C assay has become more reliable, harmonized and inexpensive.
Guido Filler, MD, PhD, FRCPC
Chair/Chief, Department of Paediatrics,
Schulich School of Medicine and Dentistry,
University of Western Ontario
Learn why Cystatin C is currently the best endogenous marker of GFR and why Beta trace protein may be better for pregnancy and neonates.
Luigi M Biasucci, M.D., FACC, FESC
Department of Cardiovascular Medicine
Institute of Cardiology
Catholic University of the Sacred Heart
Watch and learn how C-reactive protein is an established marker for diagnosing and monitoring infection, inflammation, and tissue injury.
JP Cristol, M Morena, N Kuster, AS Bargnoux, AM Dupuy.
Biochemistry and Hormonology Department
Montpellier University Hospital
Nontraditional factors are involved in CKD-related heart disease. Learn how to interpret cardiac biomarkers in CKD.
Medical Clinic V, Medical Faculty Mannheim, University of Heidelberg;
Clinical Institute of Medizical and Chemical Laboaratory Diagnostics, Medical University of Graz; Synlab Academy, Mannheim
Watch late-breaking news on inflammation and the impact of SAA on cardiovascular risk in the LURIC study.
Dept. of Gastroenterology & Hepatology
Medical University Innsbruck, Austria
Join our complimentary webcast to learn why IgG4 immunostaining is essential for the pathological diagnosis of IgG4-related disease.
Tariq Shafi, MBBS, MHS
Johns Hopkins University, Baltimore, USA
Residual Kidney Function (RKF) is an important contributor to dialysis clearance and a strong predictor of survival in dialysis patients. Learn more.
Prof. Dr. R. Woitas
BTP - a robust and reliable marker for estimation of residual kidney function
Dr. K. Lopau
Residual renal function in dialysis patients: Why this is important to know
Prof. Dr. G. Merlini
Understand the impact that the free light chain (FLC) assay has had on improvements in screening, risk assessment, and the evaluation of therapy response for monoclonal gammopathies.
Dr. J.F.M. Jacobs
Radboud University Medical Center
Nijmegen, the Netherlands
Learn more about the need for established FLC reference ranges.